Clinical perspectives on the management of community-acquired pneumonia

Diagnostic Microbiology and Infectious Disease

Volumn 25, Issue 4, 1996, Pages 205-211

  Garau, Javier ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFACLOR; CEFIXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CLAVULANIC ACID; ERYTHROMYCIN; GLYCOPEPTIDE; PENICILLIN G; SULFAMETHOXAZOLE; TEICOPLANIN; TRIMETHOPRIM; VANCOMYCIN;

AGE; ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMONIA, BACTERIAL; PROGNOSIS;

EID: 0030220447     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00136-8     Document Type: Conference Paper

References (38)

1. American Thoracic Society (1993) Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Resp Dis 148:1418-1426.
2. Ansola P, Sobradillo V, Baranda L, Gaztelurrutia L, Llorente JL, Antoñana JM (1990) Neumonías adquiridas en la comunidad de Vizcaya. Arch Bronconeumol 26:103-107.
3. Ball P (1991) The role of temafloxacin in the community setting: an overview. J Antimicrob Chemother 28:121-130.
4. Baquero F (1995) Pneumococcal resistance to beta-lactam antibiotics: A global geographic overview. Microb Drug Resist 1:115-120.
5. Billas A (1990) Lower respiratory tract infections. Prim Care 17:811-824.
6. Chan R, Hemeryck L, O'Regan M, Clancy L, Feely J (1995) Oral versus intravenous antibiotics for community-acquired lower respiratory tract infection in a general hospital: Open, randomised, controlled trial. Br Med J 310:1360-1362.
7. Coonrod JD (1989) Pneumococcal pneumonia. Semin Respir Infect 4:64-72.
8. Crossley KB, Thurn JR (1992) Nursing home acquired pneumonia. Semin Resp Infect 4:64-71.
9. Dorca J, Esteban L, Alonso T, Barreiro B, Verdaguer R, Manresa F (1993) Rapid diagnosis of pneumococcal pneumonia by latex agglutination and CIE in samples obtained by transthoracic needle aspiration. Am Rev Resp Dis 147:A653.
10. Dorca J, Manresa F, Esteban et al. (1990) Therapeutical relevance of transthoracic aspiration with ultrathin needle in bacterial lung infections. Am Rev Resp Dis 141:A278.
11. Duchin JS, Breiman RF (1993) The evolution of pneumococcal disease: Emerging challenges for control. In "Penicillin-resistant pneumococci." Proceedings, Paris. Gardner-Caldwell Communications, Macclesfield UK, 15-22.
12. Farr BM Kaiser DL, Harrison DBW, Connolly CK (1989) Prediction of microbial etiology at admission to hospital for pneumonia from the presenting clinical features. Thorax 44:1031-1035.
13. Fenoll A, Martin Bourgon C, Muñoz R, Vicioso D, Casal J (1991) Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infection in Spain, 1979-1989. Rev Infect Dis 13:56-60.
14. Fine MJ, Smith DN, Singer DE (1990) Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am J Med 89:713-721.
15. Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA, Kapoor WN (1996) Prognosis and outcomes of patients with community-acquired pneumonia. JAMA 275:134-141.
16. Fremaux A, Sissia G, Cohen R, Geslin P (1992) In vitro antibacterial activity of RP59500, a semisynthetic streptogramin, against Streptococcus pneumoniae. J Antimicrob Chemother 30(Suppl A):19-23.
17. Friedland IR, Klugman KP (1992) Antibiotic-resistant pneumococcal disease in South African children. Am J Dis Child 146:920-923.
18. Garb JL, Brown RB, Tuthill RW (1979) Differences in etiology of pneumonias in nursing home and community patients. JAMA 240:2169-2172.
19. Geslin P, Bou-Hoi A, Fremaux A Acar J (1992) Antimicrobial resistance in Streptococcus pneumoniae: An epidemiological survey in France 1970-1980. Clin Infect Dis 15:95-98.
20. Goldstein FW, Acar JF (1996) Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae - results of a 1992-93 Western European and United States Collaborative Surveillance Study. J Antimicrob Chemother 38:(Suppl A):71-84.
21. Goldstein F, Garau J (1994) Resistant pneumococci: a new threat in respiratory infections. Scand J Infect Dis 93:55-62.
22. Govan JR, Nelson JW (1992) Microbiology of lung infection in cystic fibrosis. Br Med Bull 48:912-930.
23. Jacobs M, Visalli M, Appelbaum P (1995) Anti-pneumococcal activity of CP-99.219, ciprofloxacin, lomefloxacin, clinafloxacin, sparfloxacin and cefuroxime by time-kill testing. Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Ca. F-233.
24. Klugman KP (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Review 1990 2:171-196.
25. Linares J, Latorre C, Ardenui C, Muñoz C, Tubau F, Martín R (1994) Antimicrobial resistance among Streptococcus pneumoniae strains from children and adults isolated in two hospitals in Barcelona, 1991-1993. Program and Abstracts of The 34th Interscience Conference of Antimicrobial Agents and Chemotherapy, Orlando, Florida, No. 1079.
26. Liñares J, Tubau F, Alcaide F, Mariscal D, Ardanuy C, Martin R (1993) Actividad bactericida de 5 antibióticos betalactámicos trente a Streptococcus pneumoniae. Enferm Infecc Microbiol Clin 11:23-27.
27. Lode H, Garau J, Grassi G, et al. (1995) Treatment of community-acquired pneumonia: a comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin in a three arms randomized trial using an equivalence approach. Eur Respir J 8:1897-1905.
28. Mandell LA (1995) Community-acquired pneumonia. Etiology, epidemiology and treatment. Chest 108:S35-S42.
29. Mandell LA, Niederman M, The Canadian Community-acquired Pneumonia Consensus Conference Group (1993) Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can J Infect Dis 4:25-28.
30. Manresa F, Dorca J, Gudiol F, et al. (1994) Procaine penicillin is still appropriate for pneumococcal pneumonia. Thorax 49:1067-1068.
31. Nava JM, Bella J, Garau J, Lite J, Morera MA, Marti C, Fontanals D, Font B, Pineda V, Uriz S, et al. (1994) Invasive disease due to penicillin-resistant Streptococcus pneumoniae: A population-based study. Clin Infect Dis 19:884-890.
32. Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F (1995) Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 333:474-480.
33. Palmer DL, Jones CC (1988) Diagnosis of pneumococcal pneumonia. Semin Resp Infect 3:131-139.
34. Pennington JE (1989) Community-acquired pneumonia and acute bronchitis. In Pennington JE, Ed. Respiratory Infections: Diagnosis an management. New York, Raven Press 159-170.
35. Sanchez C, Armengol R, Lite J, Mir I, Garau J (1992) Penicillin-resistant pneumococci and community-acquired pneumonia. Lancet 339:988.
36. Soriano F, Ponte C, Nieto E, Parra A (1996) Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cetotaxime in a murine model of pneumococcal pneumonia. J Antimicrob Chemother 38:227-236.
37. Woodhead M (1994) Pneumonia in the elderly. J Antimicrob Chemother 34:(Suppl A):85-92.
38. Woodhead MA, McFarlane JT (1987) Comparative clinical laboratory features on Legionella with Pneumococcal and Mycoplasma pneumonias. Br J Dis Chest 81:313-319.